Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,614 across all filing types
Latest filing 2025-12-02 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding abnormal stock price fluctuations over a specific period. It includes statements about the company's verification of information, confirmation of no undisclosed material information, and risk warnings to investors. The document is short (1012 characters) and serves as a regulatory disclosure about stock trading activity rather than a financial report or detailed analysis. It does not contain financial statements, management discussion, or detailed report data. This type of announcement fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-12-02 Chinese
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations for Shenzhen Haiwang Bioengineering Co., Ltd. It explains the situation, confirms no undisclosed material information, and provides risk warnings. The document is short (1015 characters) and does not contain financial statements or detailed financial data. It is a regulatory announcement related to stock trading behavior and compliance with disclosure rules, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2025-11-27 Chinese
关于为控股子公司提供担保实施情况的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the provision of guarantees by the parent company for its subsidiaries' borrowings from various banks and financial institutions. It includes specifics about guarantee amounts, contract parties, guarantee scope, and guarantee periods. The document is an official announcement of guarantee activities and does not contain financial statements, earnings data, or management discussion of financial results. It is not a report like an Annual Report or Interim Report, nor is it a call transcript or a voting result announcement. It is a regulatory announcement about financing-related guarantees provided by the company. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about financing guarantees, supporting this classification with high confidence.
2025-11-26 Chinese
关于参加2025年度深圳辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day event, organized by regulatory and investor service bodies. It mentions interaction with investors regarding company performance, governance, strategy, and sustainability, but does not contain any financial statements, detailed financial data, or formal report content. The document is short (552 characters) and serves as a notice of an event rather than a report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-11-12 Chinese
关于对外担保进展暨解除对外担保的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Haier Bioengineering Co., Ltd. regarding the progress and release of external guarantees. It details the company's guarantee obligations, their release, and related financial figures. The content is about a specific corporate action related to guarantees and does not contain financial statements or detailed financial performance data. It is not a full report like an Annual Report or Interim Report, nor is it a certification or voting result. It is a regulatory announcement about guarantee status, which fits best under Regulatory Filings (RNS). The document length is short and focused on a specific corporate disclosure, not a full report or presentation.
2025-11-10 Chinese
第十届董事局第三次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a formal announcement of the resolution passed at the third meeting of the tenth board of directors of Shenzhen Haiwang Bioengineering Co., Ltd. The key point is that the board approved the '2025 Third Quarter Report' and refers readers to the full report published in various newspapers and on the official information disclosure platform. The document itself does not contain the actual financial data or the report content but serves as a notice of the board meeting decision and points to where the full quarterly report can be found. Given the short length (562 characters) and the nature of the content (announcement of approval and reference to the report elsewhere), this fits the criteria for a Report Publication Announcement (RPA) rather than the Interim/Quarterly Report (IR) itself.
2025-10-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.